A clinical study to evaluate the effect of Gokshuradi Kwath on Essential Hypertension

Clinical Evaluation of Gokshuradi Kwath in Essential Hypertension - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096164

Enrollment

Registered

2025-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing for trial and who sign the consent form. 2.Patients in age group between 30-60 years. 3.Patients who are freshly diagnosed with stage-1 hypertension (i.e. Systolic Blood Pressure 140-159 mm of Hg and Diastolic Blood Pressure 90-99 mm of Hg according to JNC 8. 4.Hypertension associated with/without disturbed lipid profile.

Exclusion criteria

Exclusion criteria: 1.Patients not willing for trial. 2.Patients less than 30 years and greater than 60 years of age. 3.Patient suffering from Stage 2 hypertension i.e. Systolic grater or equal to 160 mmHg and Diastolic grater or equal to 100 mmHg and isolated systolic Hypertension (i.e. Systolic Blood Pressure grater than 140 mmHg and Diastolic Blood Pressure less than 90 mmHg). 4.Patients suffering from secondary hypertension. 5.Patients taking any other Anti Hypertensive Drug. 6.Patient suffering from any other concommitent disease like Diabetes, Cardiovascular illness, Renal disease, Neurological illness and any other comorbidity. 7.Pregnant and lactating mothers will be excluded. 8.Patients who had participated in any clinical study/trial in past 6 months. 9.Any other condition which the principal investigator thought may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
Relief in Subjective Parameters: 1.Shiroruja 2.Bhrama 3.Hridadrava 4.Swasa KricchritaTimepoint: Assesment will be done on 0 day (before treatment), and on 15th and 30th day (after the initiation of trial).	—

Secondary

Measure	Time frame
Relief in Objective Criteria: 1.Systolic and Diastolic Blood Pressure. 2.Pulse Pressure 3.Mean Arterial Pressure 4.Pulse PressureTimepoint: Assessment will be done on 0 day (before treatment) and on 15th and 30th day (after the initiation of trial).	—

Countries

India

Contacts

Public ContactNidhi

Quadra Institute of Ayurveda and Hospital Roorkee Haridwar

drrajnikant83@gmail.com8054114530

Outcome results